dalteparin has been researched along with Coagulation, Disseminated Intravascular in 18 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 77-year-old man developed chronic disseminated intravascular coagulation (DIC) after surgical repair of a large infrarenal aortic aneurysm." | 5.31 | Chronic disseminated intravascular coagulation after surgery for abdominal aortic aneurysm: clinical and haemostatic response to dalteparin. ( Awad, R; Cummins, D; Hunt, BJ; Maddox, A; Segal, H, 2001) |
| "In rat tissue factor-induced disseminated intravascular coagulation (DIC) models, an intravenous administration of danaparoid inhibited the decrease in plasma fibrinogen and platelet counts and the increase in serum fibrinogen degradation products." | 5.31 | The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated intravascular coagulation and bleeding time in the rat. ( Fujishima, Y; Miyake, Y; Sukamoto, T; Yokota, K, 2001) |
| "The effect of dalteparin, a low molecular weight heparin, on severely antithrombin III (ATIII)-decreased disseminated intravascular coagulation (DIC) model was compared with that of unfractionated heparin (heparin)." | 3.69 | Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits. ( Fukuyama, J; Hamano, S; Ichikawa, K; Misawa, K; Miyata, H; Sakuragawa, N; Tazawa, S, 1995) |
| "In 29 patients with disseminated intravascular coagulation, mean plasma sGPVI was 53." | 1.37 | Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. ( Al-Tamimi, M; Andrews, RK; Berndt, MC; Gardiner, EE; Grigoriadis, G; Paul, E; Servadei, P; Tran, H, 2011) |
| "A CT scan demonstrated abdominal aortic aneurysm (AAA) as an underlying disorder." | 1.35 | [Disseminated intravascular coagulation in abdominal aortic aneurysm--case report]. ( Chojnowski, K; Stelagowski, M; Treliński, J, 2009) |
| "A 77-year-old man developed chronic disseminated intravascular coagulation (DIC) after surgical repair of a large infrarenal aortic aneurysm." | 1.31 | Chronic disseminated intravascular coagulation after surgery for abdominal aortic aneurysm: clinical and haemostatic response to dalteparin. ( Awad, R; Cummins, D; Hunt, BJ; Maddox, A; Segal, H, 2001) |
| "In rat tissue factor-induced disseminated intravascular coagulation (DIC) models, an intravenous administration of danaparoid inhibited the decrease in plasma fibrinogen and platelet counts and the increase in serum fibrinogen degradation products." | 1.31 | The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated intravascular coagulation and bleeding time in the rat. ( Fujishima, Y; Miyake, Y; Sukamoto, T; Yokota, K, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Chojnowski, K | 2 |
| Treliński, J | 2 |
| Wawrzyniak, E | 1 |
| Robak, T | 1 |
| Betrosian, AP | 1 |
| Theodossiades, G | 1 |
| Lambroulis, G | 1 |
| Kostantonis, D | 1 |
| Balla, M | 1 |
| Papanikolaou, M | 1 |
| Georgiades, G | 1 |
| Barkagan, ZS | 1 |
| Miljić, P | 1 |
| Colović, MD | 1 |
| Suvajdzić, N | 1 |
| Casucci, G | 1 |
| Acanfora, D | 1 |
| Ardillon, L | 1 |
| Lambert, C | 1 |
| Eeckhoudt, S | 1 |
| Boon, LM | 1 |
| Hermans, C | 1 |
| Bertini, G | 1 |
| Perugi, S | 1 |
| Dani, C | 1 |
| Prisco, D | 1 |
| Fonda, C | 1 |
| Petit, JS | 1 |
| Murat, O | 1 |
| Perrier, S | 1 |
| Lepouse, C | 1 |
| Jaussaud, M | 1 |
| Léon, A | 1 |
| Stelagowski, M | 1 |
| Al-Tamimi, M | 1 |
| Grigoriadis, G | 1 |
| Tran, H | 1 |
| Paul, E | 1 |
| Servadei, P | 1 |
| Berndt, MC | 1 |
| Gardiner, EE | 1 |
| Andrews, RK | 1 |
| Gillis, S | 1 |
| Dann, EJ | 1 |
| Eldor, A | 1 |
| Koyama, T | 1 |
| Majumdar, G | 1 |
| Sakuragawa, N | 2 |
| Hasegawa, H | 1 |
| Maki, M | 1 |
| Nakagawa, M | 1 |
| Nakashima, M | 1 |
| Tazawa, S | 1 |
| Ichikawa, K | 1 |
| Misawa, K | 1 |
| Fukuyama, J | 1 |
| Hamano, S | 1 |
| Miyata, H | 1 |
| Cummins, D | 1 |
| Segal, H | 1 |
| Hunt, BJ | 1 |
| Awad, R | 1 |
| Maddox, A | 1 |
| Miyake, Y | 1 |
| Yokota, K | 1 |
| Fujishima, Y | 1 |
| Sukamoto, T | 1 |
| Asakura, H | 1 |
| Ichino, T | 1 |
| Yoshida, T | 1 |
| Suga, Y | 1 |
| Ontachi, Y | 1 |
| Mizutani, T | 1 |
| Kato, M | 1 |
| Ito, T | 1 |
| Yamazaki, M | 1 |
| Aoshima, K | 1 |
| Morishita, E | 1 |
| Saito, M | 1 |
| Miyamoto, KI | 1 |
| Nakao, S | 1 |
1 review available for dalteparin and Coagulation, Disseminated Intravascular
| Article | Year |
|---|---|
[Treatment of disseminated intravascular coagulation].
Topics: Anticoagulants; Antithrombins; Benzamidines; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dis | 2010 |
3 trials available for dalteparin and Coagulation, Disseminated Intravascular
14 other studies available for dalteparin and Coagulation, Disseminated Intravascular
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia with pulmonary embolism and disseminated intravascular coagulation associated with low-molecular-weight heparin.
Topics: Arthroplasty, Replacement, Hip; Disseminated Intravascular Coagulation; Female; Humans; Immunoglobul | 2003 |
[The use of fraxiparin for the prevention and treatment of thromboembolism in patients with heparin-induced thrombocytopenia].
Topics: Adult; Disseminated Intravascular Coagulation; Drug Evaluation; Female; Heparin; Humans; Male; Middl | 1993 |
Thrombosis of lienal vein and acute consumptive coagulopathy following warfarin administration in a patient with severe protein C deficiency.
Topics: Acute Disease; Anticoagulants; Child; Disseminated Intravascular Coagulation; Humans; Male; Nadropar | 2000 |
DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination.
Topics: ChAdOx1 nCoV-19; Clinical Laboratory Techniques; COVID-19; COVID-19 Vaccines; Dexamethasone; Dissemi | 2021 |
Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations.
Topics: Adult; Anticoagulants; Blood Platelets; Dabigatran; Disseminated Intravascular Coagulation; Enoxapar | 2016 |
Cerebral venous thrombosis treated with enoxaparin in an IUGR neonate with DIC.
Topics: Anticoagulants; Brain; Cerebral Hemorrhage; Cerebral Veins; Cerebrovascular Disorders; Disseminated | 2009 |
[Headaches in a 21-year-old man with Goodpasture disease].
Topics: Anti-Glomerular Basement Membrane Disease; Anticoagulants; Chondroitin Sulfates; Combined Modality T | 2009 |
[Disseminated intravascular coagulation in abdominal aortic aneurysm--case report].
Topics: Aged, 80 and over; Anticoagulants; Aortic Aneurysm, Abdominal; Blood Transfusion; Disseminated Intra | 2009 |
Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Dissemi | 2011 |
Long-term management of chronic DIC associated with inoperable aortic aneurysm with low molecular weight heparin.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aort | 2004 |
Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits.
Topics: Animals; Anticoagulants; Antithrombin III; Dalteparin; Disease Models, Animal; Disseminated Intravas | 1995 |
Chronic disseminated intravascular coagulation after surgery for abdominal aortic aneurysm: clinical and haemostatic response to dalteparin.
Topics: Aged; Anticoagulants; Antithrombins; Aortic Aneurysm, Abdominal; Chronic Disease; Dalteparin; Dissem | 2001 |
The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated intravascular coagulation and bleeding time in the rat.
Topics: Animals; Anticoagulants; Antithrombin III; Bleeding Time; Chondroitin Sulfates; Dalteparin; Dermatan | 2001 |
Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
Topics: Animals; Anticoagulants; Antithrombin III; Biomarkers; Blood Proteins; Dalteparin; Disseminated Intr | 2002 |